Variant report
Variant | nsv1026544 |
---|---|
Chromosome Location | chr9:22740232-22789354 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:37)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:9)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:37 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr9:22766124-22766157 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | CEBPB | chr9:22776317-22776520 | A549 | lung: | n/a | chr9:22776409-22776418 chr9:22776407-22776418 |
3 | CEBPB | chr9:22776252-22776563 | IMR90 | lung: | n/a | chr9:22776409-22776418 chr9:22776407-22776418 |
4 | CEBPB | chr9:22776328-22776436 | H1-hESC | embryonic stem cell: | n/a | chr9:22776409-22776418 chr9:22776407-22776418 |
5 | CEBPB | chr9:22776272-22776557 | HepG2 | liver: | n/a | chr9:22776409-22776418 chr9:22776407-22776418 |
6 | CTCF | chr9:22773047-22773120 | Spleen_OC | spleen: | n/a | n/a |
7 | CTCF | chr9:22778405-22778427 | Pancreas_OC | pancreas: | n/a | n/a |
8 | MAFF | chr9:22766451-22766699 | HepG2 | liver: | n/a | chr9:22766593-22766611 |
9 | MAFK | chr9:22766544-22766655 | Hela-S3 | cervix: | n/a | chr9:22766595-22766610 |
10 | MAFK | chr9:22766439-22766762 | HepG2 | liver: | n/a | chr9:22766595-22766610 |
11 | MAFK | chr9:22766491-22766741 | HepG2 | liver: | n/a | chr9:22766595-22766610 |
12 | MAFK | chr9:22766484-22766677 | IMR90 | lung: | n/a | chr9:22766595-22766610 |
13 | MAFK | chr9:22763062-22763162 | IMR90 | lung: | n/a | n/a |
14 | MYC | chr9:22764734-22764856 | GM12878 | blood: | n/a | n/a |
15 | NFYA | chr9:22741003-22741151 | GM12878 | blood: | n/a | n/a |
16 | POLR2A | chr9:22773436-22773636 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | POLR2A | chr9:22773564-22774308 | H1-neurons | neurons: | n/a | n/a |
18 | POLR2A | chr9:22773502-22774342 | H1-neurons | neurons: | n/a | n/a |
19 | POLR2A | chr9:22764690-22764858 | Gliobla | brain: | n/a | n/a |
20 | POLR2A | chr9:22755197-22755280 | GM12878 | blood: | n/a | n/a |
21 | POLR2A | chr9:22787623-22787731 | ProgFib | skin: | n/a | n/a |
22 | POLR2A | chr9:22775664-22775857 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | POLR2A | chr9:22785562-22785692 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | POLR2A | chr9:22779762-22779956 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | POLR2A | chr9:22766297-22766471 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | REST | chr9:22773446-22774411 | H1-neurons | neurons: | n/a | n/a |
27 | REST | chr9:22773302-22774514 | H1-neurons | neurons: | n/a | n/a |
28 | RXRA | chr9:22785556-22785705 | HepG2 | liver: | n/a | n/a |
29 | SPI1 | chr9:22759413-22759537 | K562 | blood: | n/a | n/a |
30 | SPI1 | chr9:22759405-22759552 | GM12878 | blood: | n/a | n/a |
31 | SPI1 | chr9:22759423-22759532 | K562 | blood: | n/a | n/a |
32 | SPI1 | chr9:22759320-22759583 | GM12891 | blood: | n/a | n/a |
33 | SPI1 | chr9:22759401-22759579 | GM12891 | blood: | n/a | n/a |
34 | STAT3 | chr9:22751426-22751626 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | STAT3 | chr9:22778309-22778509 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | STAT3 | chr9:22777307-22777507 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | STAT3 | chr9:22782174-22782464 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:9 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DMRTA1-1 | chr9:22767174-22767265 | ENSG00000224549 |
2 | lnc-DMRTA1-13 | chr9:22757961-22758315 | NONHSAT130448 |
3 | lnc-DMRTA1-14 | chr9:22759737-22759837 | NONHSAT130447 |
4 | lnc-DMRTA1-13 | chr9:22757174-22757265 | NONHSAT130448 |
5 | lnc-DMRTA1-1 | chr9:22767961-22768315 | ENSG00000224549 |
6 | lnc-DMRTA1-14 | chr9:22754997-22755223 | NONHSAT130447 |
7 | lnc-DMRTA1-14 | chr9:22764211-22764434 | NONHSAT130447 |
8 | lnc-DMRTA1-1 | chr9:22767106-22768486 | NONHSAT130449 |
9 | lnc-DMRTA1-1 | chr9:22767174-22767298 | NONHSAT130443 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000236739 | TF binding region |
ENSG00000224549 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7872081 | chr9:22740232-22740233 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs565966404 | chr9:22740253-22740254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs566888417 | chr9:22740259-22740260 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs180979099 | chr9:22740274-22740275 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs581381 | chr9:22740301-22740302 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs551420407 | chr9:22740308-22740309 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568015075 | chr9:22740320-22740321 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs536915909 | chr9:22740325-22740326 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs571420643 | chr9:22740328-22740329 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs471095 | chr9:22740332-22740333 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs576942517 | chr9:22740365-22740366 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539556148 | chr9:22740370-22740371 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536754404 | chr9:22740393-22740394 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552784545 | chr9:22740411-22740412 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572843283 | chr9:22740452-22740453 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs376155689 | chr9:22740454-22740455 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561628089 | chr9:22740472-22740473 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576023475 | chr9:22740473-22740474 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs143567216 | chr9:22740506-22740507 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533346414 | chr9:22740526-22740527 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs146823987 | chr9:22740547-22740548 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560377067 | chr9:22740580-22740581 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs529339630 | chr9:22740586-22740587 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs7872271 | chr9:22740627-22740628 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs148943814 | chr9:22740657-22740658 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs536979980 | chr9:22740660-22740661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs550447886 | chr9:22740672-22740673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557233492 | chr9:22740699-22740700 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79070599 | chr9:22740723-22740724 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575097306 | chr9:22740732-22740733 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75843519 | chr9:22740733-22740734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs77524965 | chr9:22740761-22740762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111546292 | chr9:22740783-22740784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535508904 | chr9:22740804-22740805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555422967 | chr9:22740818-22740819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs139049505 | chr9:22740844-22740845 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532725147 | chr9:22740845-22740846 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575289374 | chr9:22740863-22740864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs186437299 | chr9:22740883-22740884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564613246 | chr9:22740885-22740886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs111663963 | chr9:22740910-22740911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs142305223 | chr9:22740924-22740925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557820438 | chr9:22740953-22740954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560692256 | chr9:22741005-22741006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs533904191 | chr9:22741020-22741021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114578195 | chr9:22741022-22741023 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368086566 | chr9:22741073-22741074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs186559653 | chr9:22741129-22741130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531590095 | chr9:22741134-22741135 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550509887 | chr9:22741139-22741140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Cancer | 22183965 | CNVD |
Glioblastoma multiforme | 21569311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Lung cancer | 21911935 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
head and neck squamous cell carcinoma | 21798897 | CNVD |
Cancer | 21253487 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Glioma | 17123091 | CNVD |
Mental retardation | 17124404 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Leukemia | 19602459 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Leukemia | 18688285 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Coronary Disease | 20032323 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21732550 | CNVD |
Gastric cancer | 22539939 | CNVD |
Cancer | 21183584 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cervical cancer | 21062161 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Glioblastoma | 17090523 | CNVD |
Lung cancer | 16773561 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Bladder cancer | 19088036 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 16977458 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Chagasic megaesophagus | 20163722 | CNVD |
Melanoma | 19566914 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Glioma | 20126413 | CNVD |
Melanoma | 17363583 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Cancer | 20581869 | CNVD |
Oral cancer | 22144094 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21525872 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:22725800-22801600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr9:22738800-22778800 | Weak transcription | Liver | Liver |
3 | chr9:22739800-22740600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr9:22740600-22742600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr9:22742600-22742800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr9:22749200-22749400 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr9:22755000-22755400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr9:22763800-22803600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr9:22767600-22770200 | Weak transcription | Adipose Nuclei | Adipose |
10 | chr9:22770400-22770800 | Enhancers | Fetal Brain Male | brain |
11 | chr9:22770600-22771000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr9:22770800-22771000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr9:22770800-22771200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
14 | chr9:22771000-22773400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
15 | chr9:22771200-22773200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
16 | chr9:22772800-22773000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
17 | chr9:22773000-22774200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr9:22773200-22774200 | Enhancers | HUES64 Cell Line | embryonic stem cell |
19 | chr9:22773400-22774200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr9:22773400-22774400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
21 | chr9:22773600-22774200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
22 | chr9:22773800-22774200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |